Zimbabwe has declined a significant American health deal valued at $367m (272 million pounds) over five years because of Washington's insistence on sensitive data.
This rejection was revealed after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government representative has since explained that the US was demanding access to health data for research and commercial gain while refused to share the benefits from any future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged further talks to find a agreement suitable to both sides so the country's vital HIV programme can proceed.
Wider Background
This rejection follows a similar situation in Kenya, where a high court suspended a related health funding agreement following concerns were filed about the security of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
USAID had overseen assistance for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.
According to reports, 16 African countries have so far agreed to these new health pacts, representing more than $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million currently receiving HIV treatment via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our country would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our people should a future disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining systems previously set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future pandemics.
"This mechanism is intended to ensure that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future co-operation might be structured in a manner that honours the sovereignty and interests of both nations."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that talks must proceed since a large portion of the country's HIV programmes were funded by external financing.
"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it added.
This impasse underscores the complex tensions between receiving much-needed foreign assistance and protecting local interests in an increasingly data-driven world.